Indirect cost burden of migraine in the United States

The purpose of this study was to determine the indirect cost burden associated with migraine. Data were obtained from Thomson-Medstat's Health and Productivity Management (HPM) database for the 2002 through 2003 calendar years. The migraine cohort was composed of patients who had a diagnosis of...

Full description

Saved in:
Bibliographic Details
Published inJournal of occupational and environmental medicine Vol. 49; no. 4; p. 368
Main Authors Hawkins, Kevin, Wang, Sara, Rupnow, Marcia F T
Format Journal Article
LanguageEnglish
Published United States 01.04.2007
Subjects
Absenteeism
Adult
Case-Control Studies
Cohort Studies
Cost of Illness
Costs and Cost Analysis
Databases as Topic
Efficiency
Employer Health Costs - statistics & numerical data
Female
Health Expenditures - trends
Humans
Male
Migraine Disorders - economics
United States
United States
Online AccessGet more information

Cover

More Information
Summary:The purpose of this study was to determine the indirect cost burden associated with migraine. Data were obtained from Thomson-Medstat's Health and Productivity Management (HPM) database for the 2002 through 2003 calendar years. The migraine cohort was composed of patients who had a diagnosis of migraine or migraine-specific abortive prescription medication, or both. A control cohort of patients without migraine was matched to patients in the migraine cohort. The average annual indirect burden of illness (BOI) of migraine and a national indirect BOI were estimated. Annual indirect expenditures were significantly higher in the migraine group compared with the control group ($4453 vs $1619; P<0.001). The national annual indirect BOI, excluding presenteeism, was estimated to be $12 billion (mostly attributed to absenteeism). Migraine imparts a substantial indirect cost burden. Projected to a national level, this amounts to an annual cost to US employers of approximately $12 billion.
ISSN:1076-2752
DOI:10.1097/JOM.0b013e31803b9510